Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | solute carrier family 1 (glial high affinity glutamate transporter | 0.0146 | 0.3577 | 1 |
Wolbachia endosymbiont of Brugia malayi | Na+/H+-dicarboxylate symporter | 0.0146 | 0.3577 | 0.5 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.0146 | 0.3577 | 1 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.0146 | 0.3577 | 1 |
Onchocerca volvulus | Excitatory amino acid transporter homolog | 0.0146 | 0.3577 | 0.5 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.0146 | 0.3577 | 1 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.0146 | 0.3577 | 1 |
Mycobacterium tuberculosis | Probable C4-dicarboxylate-transport transmembrane protein DctA | 0.0146 | 0.3577 | 0.3577 |
Echinococcus multilocularis | sodium:dicarboxylate symporter | 0.0146 | 0.3577 | 1 |
Echinococcus granulosus | neutral amino acid transporter A | 0.0146 | 0.3577 | 1 |
Chlamydia trachomatis | glutamate symporter | 0.0146 | 0.3577 | 0.5 |
Echinococcus granulosus | sodium:dicarboxylate symporter | 0.0146 | 0.3577 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 3 | 0.0146 | 0.3577 | 1 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.0146 | 0.3577 | 1 |
Loa Loa (eye worm) | excitatory amino acid transporter | 0.0146 | 0.3577 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter | 0.0146 | 0.3577 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0146 | 0.3577 | 1 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0146 | 0.3577 | 1 |
Echinococcus granulosus | neutral amino acid transporter A | 0.0146 | 0.3577 | 1 |
Echinococcus multilocularis | excitatory amino acid transporter 3 | 0.0146 | 0.3577 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0 | 0.5 |
Brugia malayi | Excitatory amino acid transporter | 0.0146 | 0.3577 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.0146 | 0.3577 | 1 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.0146 | 0.3577 | 1 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0146 | 0.3577 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.0146 | 0.3577 | 1 |
Echinococcus multilocularis | neutral amino acid transporter excitatory amino acid transporter | 0.0146 | 0.3577 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0828 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 0.631 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.